Dr. Aaron S. Kesselheim, MD

Dr. Kesselheim practices at Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham.

Dr. Kesselheim's NPI, 1063478626, was assigned on April 24, 2006. Dr. Kesselheim graduated from Perelman School of Med at the University of Pennsylvania in 2002. Dr. Kesselheim holds Massachusetts license 223102.

Dr. Kesselheim's primary practice is Brigham and Women's Hospital, at 75 Francis Street, Boston, MA 02115 in Suffolk County. The practice phone is (617) 732-5500.

Dr. Kesselheim's primary practice is Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham. Dr. Kesselheim is also affiliated with Massachusetts General Hospital. The medical group on file is Brigham and Women's Hospital. Dmand AI also links Dr. Kesselheim to 1 more hospital, 1 home health agency and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kesselheim practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Kesselheim's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Kesselheim is licensed in Massachusetts.

CMS data shows 60 Medicare services from Dr. Kesselheim across 2 procedure codes in 2024, all of them office visits, for 39 Medicare patients. Medicare paid $3,823 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 39 Medicare patients who saw Dr. Kesselheim in 2024. The largest group is 65 to 74, with 17 patients. 69% of them have high blood pressure, and 62% have high cholesterol. 38% are also on Medicaid. Their average risk score is 1.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kesselheim's median patient age at 72, with 38% women.

In 2024, Dr. Kesselheim wrote 906 Medicare Part D claims for 78 patients. 90% of them were for generic drugs. CMS names the drug for 610 of them, across 25 drugs with 11 or more claims each, at $23,908 in total drug cost. In 2023, CMS named 670 claims across 27 drugs.

Dr. Kesselheim accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kesselheim as offering telehealth.

Dmand AI links 763 papers to Dr. Kesselheim, published from 2010 to 2025. 2024 was the busiest year, with 44. The most frequent topics are United States Food and Drug Administration, Drug Approval and Drug Industry. Dr. Kesselheim has published most often in JAMA. Dr. Kesselheim's most frequent co-authors are Daniel Bruce Kramer, MD, MPH, Niteesh Kumar Choudhry, MD, PhD and Steven Woloshin, MD.

Dr. Kesselheim graduated from Perelman School of Med at the University of Pennsylvania in 2002.